Professional Documents
Culture Documents
Index of Pharmacopoeias - 17012018 PDF
Index of Pharmacopoeias - 17012018 PDF
10
January 2018
Original: English
The Index of World Pharmacopoeias and Pharmacopoeial Authorities has been circulated to national and regional
pharmacopoeia secretariats and to pharmacopoeial authorities for their feedback and the data received from them
have been used to update the list. Links to online pharmacopoeias have been provided where available. Where no
specific links to online pharmacopoeias are available, links to organizations of national or regional pharmacopoeia
commissions are listed.
The list is provided for reference purposes only and does not pretend to be complete.
In order to bring this list up to date we would appreciate any additional data you may have. Please address your
observations to Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies Standards and Norms,
World Health Organization, 1211 Geneva 27, Switzerland; email: kopps@who.int with a copy to finnertyk@who.int.
_______________________________________________________________________________________________________________________
Index of pharmacopoeias
© World Health Organization 2018
All rights reserved.
Working document QAS/11.453/Rev.10
page 2
Table of contents
page
I. NATIONAL………………………………………………………………………..………………………………………………………………………………………………………………………4
Argentina .................................................................................................................................................................................................................. 4
Austria* ..................................................................................................................................................................................................................... 5
Belarus** ................................................................................................................................................................................................................... 5
Belgium* ................................................................................................................................................................................................................... 5
Bosnia and Herzegovina*………………………………………………………………………………………………………………………………………...5
Brazil ......................................................................................................................................................................................................................... 6
Bulgaria*……………………………………………………………………………………………………………………………………………………………8
Chile ………………………………………………………………………………………………………………………………………………………………..8
China ......................................................................................................................................................................................................................... 8
Croatia* ..................................................................................................................................................................................................................... 9
Cyprus*………………………………………………………………………………………………………………………………………………….………….9
Czech Republic*..................................................................................................................................................................................................... 10
Denmark* ................................................................................................................................................................................................................ 11
Egypt ....................................................................................................................................................................................................................... 11
Estonia* .................................................................................................................................................................................................................. 12
Finland* ................................................................................................................................................................................................................... 32
France* .................................................................................................................................................................................................................... 12
Germany* ................................................................................................................................................................................................................ 13
Greece* ................................................................................................................................................................................................................... 14
Hungary* ................................................................................................................................................................................................................. 14
Iceland* ................................................................................................................................................................................................................... 14
India …………..…………………………………………………………………………………………………………………………………………………..14
Indonesia ................................................................................................................................................................................................................ 15
Iran .......................................................................................................................................................................................................................... 16
Ireland* .................................................................................................................................................................................................................... 16
Italy* ........................................................................................................................................................................................................................ 16
Japan ...................................................................................................................................................................................................................... 17
Kazakhstan** .......................................................................................................................................................................................................... 19
Latvia* ..................................................................................................................................................................................................................... 19
Lithuania* ............................................................................................................................................................................................................... 19
Luxembourg*……………………………………………………………………………………………………………………………………………… …..20
Working document QAS/11.453/Rev.10
page 3
Malta*………………………………….…………………………………………………………………………………………………………………………..20
Mexico..................................................................................................................................................................................................................... 21
Montenegro ............................................................................................................................................................................................................ 22
Netherlands*…………………………………………………………………………………………………………………………… ……………………...22
Norway* .................................................................................................................................................................................................................. 22
Pakistan .................................................................................................................................................................................................................. 23
Philippines.............................................................................................................................................................................................................. 23
Poland* ................................................................................................................................................................................................................... 24
Portugal* ................................................................................................................................................................................................................. 25
Romania* ................................................................................................................................................................................................................ 25
Russian Federation** ............................................................................................................................................................................................ 26
Serbia* .................................................................................................................................................................................................................... 26
Slovakia* (Slovak Republlic) ................................................................................................................................................................................ 26
Slovenia* ................................................................................................................................................................................................................. 27
Spain* ...................................................................................................................................................................................................................... 27
Sweden* .................................................................................................................................................................................................................. 27
Switzerland* ........................................................................................................................................................................................................... 28
Thailand .................................................................................................................................................................................................................. 28
Turkey* .................................................................................................................................................................................................................... 29
Ukraine* .................................................................................................................................................................................................................. 29
United Kingdom*.................................................................................................................................................................................................... 30
United States of America ...................................................................................................................................................................................... 30
Viet Nam ................................................................................................................................................................................................................. 31
The Former Yugoslav Republic of Macedonia*……………………………………………………………………………………..…………………….31
II. REGIONAL AND SUBREGIONAL…………………………………………………………………………….………………………………………………………………………..321
Eurasia …………………………………………………………………………………………..…………………………………………………………………..32
European Pharmacopoeia Members:……………………………………………………………………………………………………………………………………………………………33
Africa ........................................................................................................................................................................................................................ 34
III. INTERNATIONAL………………………………………………………………………………………………………………………………………..……………………………………….35
WHO, Geneva ......................................................................................................................................................................................................... 35
Working document QAS/11.453/Rev.10
page 4
I. NATIONAL
Argentina Farmacopea Argentina 1. & 2. Farmacopea Argentina 8th Edition* (vol.1,2,3,4) 2011 Spanish
Administración Nacional de Medicamentos, 7th Edition, vol.1 2002
Alimentos y Tecnología Médica (ANMAT) 6th Edition 1978
Avenida de Mayo 869 (C1084AAD) - Ciudad 5th Edition 1966
Autónoma de Buenos Aires, Argentina 4th Edition 1956
Website: http://www.anmat.gov.ar (Spanish) 3rd Edition 1943
Email: fa@anmat.gov.ar 2nd Edition 1921
1st Edition 1898
Belarus** Государственной 1. The Pharmacopoeial-and-Pharmaceutical Analysis 1st Edition, vol. 1 2006 Russian
фармакопеи Laboratory of the Centre for Expertise and Testing in vol. 2 2008
Республики Беларусь Health Care,The Ministry of Health of the Republic of vol. 3 2009
(State Pharmacopoeia of Belarus
the Republic of Belarus) 2a Tovarishesky Lane, Minsk, 220037, Belarus
Website: http://www.rceth.by/lffaeng.htm (Russian,
English)
Email: info@rceth.by
Brazil Brazilian Pharmacopoeia 1. & 2. Pharmacopoeia Coordination, Brazilian Health 5th Edition (5.0) 2010 Portuguese,
(Farmacopéia Brasileira) Surveillance Agency – ANVISA Supplement 5.1 2016 English,
Agência Nacional de Vigilância Sanitária – ANVISA 4th Edition Spanish
SIA, Trecho 5, Area Especial 57 Part 1 1988
Brasília - DF Part 2, Vol. 1 1996
City: Brasília – DF, CEP: 71.205-050, Brazil Vol. 2 2000
Vol. 3 2002
3. Website: http://novoportal.anvisa.gov.br/ Vol. 4 2003
(Portuguese, English) Vol. 5 2004
Vol. 6 2005
Email: farmacopeia@anvisa.gov.br 3rd Edition 1976
2nd Edition 1957
4. Yearly 1st Edition 1929
http://portal.anvisa.gov.br/documents/33832/259147/F
armacopeia+HOMEOPATICA+3a+EDICAO+INGLES+
com+alerta.pdf/49a48a50-0d3e-4ab9-bc41-
eb361c8afbb1
(English)
http://portal.anvisa.gov.br/documents/33832/259147/F
armacopeia+HOMEOPATICA+3a+EDICAO+ESPANH
OL+com+alerta.pdf/7e1f40c1-53fa-4fba-ba66-
e5e376e02051
(Spanish)
National Formulary 1,2. see above 2nd Edition 2012 Portuguese,
Working document QAS/11.453/Rev.10
page 7
(Formulário Nacional) 1st Edition 2005 English,
3. National Formulary Spanish
(Formulário Nacional)
http://portal.anvisa.gov.br/documents/33832/259372/F
NFB+2_Revisao_2_COFAR_setembro_2012_atual.pdf
/20eb2969-57a9-46e2-8c3b-6d79dccf0741
(Portuguese)
http://portal.anvisa.gov.br/documents/33832/259372/F
ormulario+NACIONAL+FARMACOPEIA+INGLES+co
m+alerta.pdf/056212ea-c30e-4f80-bf0e-63a7fdf6c149
(English)
http://portal.anvisa.gov.br/documents/33832/259372/F
ormulario+NACIONAL+FARMACOPEIA+ESPANHOL+
com+alerta.pdf/8cf5a930-fc74-4e2c-b257-
a59270e56526
(Spanish )
Herbal Medicines 1,2. see above 1st Edition 2011 Portuguese,
National Formulary English,
(Formulário Nacional 3. Herbal Medicines National Formulary Spanish
Fitoterápico)
(Formulário Nacional Fitoterápico)
http://portal.anvisa.gov.br/documents/33832/259456/F
ormulario_de_Fitoterapicos_da_Farmacopeia_Brasileir
a.pdf/c76283eb-29f6-4b15-8755-2073e5b4c5bf
(Portuguese)
http://portal.anvisa.gov.br/documents/33832/259456/F
ormulario+de+Fitoterapicos+1a+Ed.+INGLES+com+al
erta.pdf/e11dcf7b-a93d-432a-8b62-ffb921494ce9
(English)
http://portal.anvisa.gov.br/documents/33832/259456/F
ormul%C3%A1rio+de+Fitotet%C3%A1picos+1a+Ed.+
ESPANHOL+com+alerta.pdf/d869a72c-21b2-42c3-
9c64-90efb29fe064
Working document QAS/11.453/Rev.10
page 8
(Spanish)
Homeopathic Medicines 1,2. see above 1st Edition 2016 Portuguese,
National Formulary English,
(Formulário Nacional 3. Homeopathic Medicines National Formulary Spanish
Homeopático)
(Formulário Nacional Homeopático)
Herbal Medicines 1,2. see above 1st Edition 2016 Portuguese
Memento
(Memento Fitoterápico) 3. Herbal Medicines Memento
(Memento Fitoterápico)
http://portal.anvisa.gov.br/documents/33832/2909630/
Memento+Fitoterapico/a80ec477-bb36-4ae0-b1d2-
e2461217e06b
(Portuguese)
Bulgaria* Bulgarian Pharmacopoeia Commission
Bulgarian Drug Agency
Damyan Gruev Str. 8
BG-Sofia 1303
Email: sashka.toncheva@bda.bg
Pharmacopoeia of the 2. China Medico-Pharmaceutical Science & 9th Edition 2010 Chinese, English
People's Republic of Technology Publishing House 8th Edition 2005 Chinese, English
Working document QAS/11.453/Rev.10
page 9
China http://www.cmstp.com 7th Edition 2000 Chinese, English
6th Edition 1995 Chinese, English
A-22, Northern WenHuiYuan Road, Haidian District, 5th Edition 1990 Chinese, English
Beijing 100082, P. R. China 4th Edition 1985 Chinese, English
3rd Edition 1977 Chinese
2nd Edition 1963 Chinese
4. once every five years 1st Edition 1953 Chinese
Croatia* Hrvatska Farmakopeja 1. & 2 (b) Pharmacopoeia Commission Edition 3.0 2014 Croatian
HRF (Croatian Agency for Medicinal Products and Medical Devices Supplement 3.1 2014 Croatian
Pharmacopoeia) Ksaverska cesta 4, HR-10 000 Zagreb Supplement 3.2 2014 Croatian
Website: Supplement 3.3 2014 Croatian
http://www.halmed.hr/Lijekovi/Farmakopeja/Hrvatska- Supplement 3.4 2015 Croatian
farmakopeja/ (Croatian, English) Supplement 3.5 2015 Croatian
Email: hfd-fg-ap@zg.t-com.hr Supplement 3.6 2015 Croatian
Supplement 3.7 2016 Croatian
Supplement 3.8 2016 Croatian
Edition 2.0 2013 Croatian
Hrvatska Farmakopeja 2 (a) Croatian Pharmaceutical Society Hrvatska farmakopeja 2007 Croatian
(Croatian (Hrvatsko Farmaceutsko Društvo) 2007
Pharmacopoeia) Masarykova 2, 10 000 Zagreb, Croatia
Website: http://www.farmaceut.org (Croatian, English)
Email: hfd-fg-ap@zg.t-com.hr
Egypt Egyptian 1. Permanent Commission of the Egyptian 4th Edition 2005 Arabic, English
Pharmacopoeia Pharmacopoeia,The Egyptian Drug Authority 3rd Edition 1984
21 Abd El-Aziz Al Soud Street, El-Manial, Cairo, Egypt 2nd Edition 1972
Website: http://www.eda.mohp.gov.eg (Arabic, 1st Edition 1953
English)
Email: plan.imp@eda.mohealth.gov.eg
Finland*
1. FIMEA Pharmacopoeia Committee
Finnish Medicines Agency
PO Box 55, FI-000034 Helsinki
Website: http://www.fimea.fi (Finnish, Swedish,
English)
Email: fimeapharmacopoeia@fimea.fi
Pharmacopée française 2. Wolters Kluwer France 11th Edition (free online) 2012 French (regularly
1 rue Eugène et Armand Peugeot http://ansm.sante.fr/Mediatheque/Publications/Phar updated)
92856 Rueil-Malmaison cedex macopee-francaise-Plan-Preambule-index
10th Edition 2010
(Some updated texts
are in English)
4. updated yearly, Since 1998, the French
Pharmacopoeia consists of three folders regularly
Working document QAS/11.453/Rev.10
page 13
updated
4. yearly.
2. Deutscher Apotheker Verlag, Stuttgart
Govi-Verlag- Pharmazeutischer Verlag GmbH,
Eschborn
Working document QAS/11.453/Rev.10
page 14
Greece* Greek Pharmacopoeia Greek Pharmacopoeia Commission 5th Edition, vols 1, 2 1998 Greek
Pharmacopoeia Section Supplement 1 2000
National Organisation for Medicines Supplement 2 2002
Mesogeion Avenue, 284 Supplement 3 2006
Supplement 4 2009
GR-15562 Holargos Attikis
Website: http://www.eof.gr (English, Greek)
Email: amak@eof.gr
Hungary* Magyar gyógyszerkönyv 1. Hungarian Pharmacopoeia Commission (OGYI) 8th Edition 2006 Hungarian
(Pharmacopoeia National Institute for Quality and Organizational 7th Edition 1987
Hungarica) Development in Healthcare and Medicines 6th Edition 1967
National Institute of Pharmacy, Zrínyi utca 3 5th Edition 1958
H-1051 Budapest / 4th Edition 1933
PO Box 450, H-1372.Budapest 3rd Edition 1909
Website:http://www.ogyi.hu/ (Hungarian, English) 2nd Edition 1888
Email: koszegine.szalai.hilda@gyemszi.hu 1st Edition 1871
India Indian Pharmacopoeia 1.& 2.Office of the Secretary-cum-Scientific Director 8th Edition 2018 English
Indian Pharmacopoeia Commission 7th Edition 2014
Ministry of Health and Family Welfare Addendum 2015
Government of India Addendum 2016
Sector 23, Raj Nagar, Ghaziabad – 201 002, India 6th Edition 2010
Addendum 2012
3. Not online as yet, www.ipc.gov.in 5th Edition 2007
Addendum 2008
4. New Edition every 4 years and 2 addenda in between
Working document QAS/11.453/Rev.10
page 15
4th Edition 1996
Addendum 2000
Veterinary Supplement 2000
Addendum 2002
Addendum 2005
3rd Edition 1985
Addendum 1989
Addendum 1991
2nd Edition 1966
Supplement 1975
1st Edition 1955
Supplement 1960
Indonesia Farmakope Indonesia 1. Indonesian Pharmacopoeia Commission 5th Edition 2014 Indonesian
Directorate of Therapeutic Products and Household 1st Supplement 2015
Healthcare Standardization
National Agency of Drug and Food Control 4th Edition 1995
Kesehatan R.I., Jl, Percetakan 1st Supplement 2009
Negara 23, Jakarta 10560, Indonesia 2nd Supplement 2010
Website: http://www.pom.go.id (Indonesian) 3rd Supplement 2011
Emails: regobpom@indo.net.id;
standardterapetik@yahoo.com;
farmakopeindonesia@yahoo.com;
informasi@pom.go.id
2. Kementerian Kesehatan, Republik Indonesia
(Ministry of Health, Republic of Indonesia)
DJL. Kuningan
Jakarta
Working document QAS/11.453/Rev.10
page 16
Iran Iranian Pharmacopoeia 1. Iranian Pharmacopoeia 1st Edition 2013 Iranian
Drug Administration of Iran, Division of
Pharmaceuticals & Narcotic Affairs
Ministry of Health and Medical Education
PO Box 310,
Teheran 11344, Islamic Republic of Iran
Location: 14th floor, MOHME building, Simaye Iran
Street, Phase 5, Shahrake Qods, Teheran, Iran
(Islamic Republic of)
Website: http://www.mohme.gov.ir (Farsi)
Email: Lankarani@mohme.gov.ir
Italy* Farmacopea Ufficiale 1. Segreteria Tecnica della Farmacopea Ufficiale 12th Edition 2008 Italian
della Repubblica Italiana Italiana, 11th Edition 2002
Istituto Superiore di Sanità Supplement (2005)
Viale Regina Elena 299
I-00161 - Roma
Website:http://www.iss.it (English, Italian)
Email: farmcp@iss.it
2. Ministerio della Salute,Commissione
permanente per la revisione e pubblicazione
della Farmacopea Ufficiale,
Istituto Poligrafico e Zecca dello Stato P.V.,
I-1213045 Roma
Working document QAS/11.453/Rev.10
page 17
Japan The Japanese 1. Expert Committee on the Japanese Pharmacopoeia JP 17th 2016 Japanese, English
Pharmacopoeia (JP) Pharmaceuticals and Medical Devices Agency JP 16th 2011 Japanese, English
Shin-kasumigaseki Building, 16 Supplement 1 2012 Japanese, English
3-3-2, Kasumigaseki,Chiyoda-ku,Tokyo 100-0013 16 Supplement 2 2014 Japanese, English
Japan JP 15th 2006 Japanese, English
Website: http://www.pmda.go.jp/english/rs-sb- 15 Supplement 1 2007 Japanese, English
std/standards-development/jp/0009.html (Japanese, 15 Supplement 2 2009 Japanese, English
English) JP 14th 2001 Japanese, English
Email: Std-jpenghp@pmda.go.jp 14 Supplement 1 2002 Japanese, English
14 Supplement 2 2004 Japanese, English
JP 13th 1996 Japanese, English
2. Committee on the Japanese Pharmacopoeia/ 13 Supplement 1 1997 Japanese, English
Pharmaceutical Affairs Food Sanitation Council 13 Supplement 2 1999 Japanese, English
Pharmaceutical Safety and Environmental Health JP 12th 1991 Japanese, English
Bureau, 12 Supplement 1 1993 Japanese, English
Ministry of Health, Labour and Welfare 12 Supplement 2 1994 Japanese, English
1-2-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-8916, JP 11th 1986 Japanese, English
Japan 11 Supplement 1988 Japanese, English
Website: JP 10th 1981 Japanese, English
http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/000006 JP 9th 1976 Japanese, English
6597.html (Japanese, English) JP 8th 1971 Japanese, English
Email: kyokuhou@mhlw.go.jp JP 7th 1961 Japanese, English
JP 6th 1951 Japanese, English
JP 5th 1932 Japanese
3. The Japanese Pharmacopoeia JP 4th 1920 Japanese, English
http://www.pmda.go.jp/english/rs-sb-std/standards- JP 3rd 1906 Japanese, English
development/jp/0009.html (English) JP 2nd 1891 Japanese
JP 1st 1886 Japanese
4. Frequency of publication
New editions are published every 5 years and two
supplements are published between the regular
publication of JP editions.
th
Korea 1. Ministry of Food and Drug Safety 11 Edition 2014 Korean
th
Osong Health Technology Administration Complex 10 Edition 2012 Korean, English
th
187 Osongseangmyeong 2-ro, Osong-eup, 9 Edition 2007 Korean, English
Heungdeok-gu, Cheonju-si, Chuncheongbuk-do Supplement 1 2009
363-700, Korea Supplement 2 2010
Website: http://www.mfds.go.kr (Korean, English) Supplement 3 2010
Email: duri4209@korea.kr Supplement 4 2010
Supplement 5 2010
Supplement 6 2011
Supplement 7 2011
Supplement 8 2012
th
The Korean Pharmacopoeia 2. Central Pharmaceutical Affairs Council 8 Edition 2002
5-mosaemi-gil, yangchun-gu, Seoul, Korea Supplement 1 2006
th
7 Edition 1997
3. Korea Food and Drug Administration Supplement 1 2000
The Korean Pharmacopoeia
http://eng.mfds.go.kr (English)
th
6 Edition 1992
4. Currently revised every 5-year term Supplement 1 1993
th
5 Edition 1987
Supplement 1 1988
th
4 Edition 1982
Supplement 1 1982
rd
3 Edition 1976
Supplement 1 1978
Supplement 2 1979
nd
2 Edition
Part I 1967
Part II 1968
Supplement 1 1968
Supplement 2 1969
st
1 Edition 1958
Working document QAS/11.453/Rev.10
page 19
Kazakhstan** The State 1. & 2. RSE “The National Center for Expertise of Medicines, 2nd Edition 2017 Kazakh
Pharmacopoeia Medical Devices and Equipment” of 2 volumes Russian
of the Republic Ministry of Health and Social Development of the Republic of (under develop-
of Kazakhstan Kazakhstan ment and will be
(SPRK) published in
3. Website:http://www.dari.kz (Russian) 2017)
Email:farm@dari.kz 2nd Edition 2015 Kazakh
of 1st volume Russian
4. Frequency of publication 1st Edition 2014 Kazakh
3 volumes Russian
Once every 5 years. 1st Edition 2008
Online access in near future. 1, 2 vols
Latvia* Riga Stradins University
Dzirciema str. 16
LV 1007 Riga
Ilze.Barene@rsu.lv
1. Lithuania has published only one National 1st Edition 1938 Lithuanian
Lithuania*
Lithuanian Pharmacopoeia “Lietuvos Farmakopėja” in 1938.
Pharmacopoea Now we use the European Pharmacopoeia.
(Lietuvos 2. Lithuanian Pharmacopoeia Authority:
Farmakopėja) State Medicines Control Agency under the
Ministry of Health of the Republic of Lithuania
Zirmunu str. 139A
LT-09120 Vilnius
Working document QAS/11.453/Rev.10
page 20
3. Website: http://www.vvkt.lt (Lithuanian,
English)
Email: romamockute@vvkt.lt
Government of Pakistan
Web site: http://www.pakistan.gov.pk (English)
Poland* Farmakopea 1. Pharmacopoeia Commission 10th Edition (and supplements) 2014- Polish
Polska Pharmacopoeia Department 9th Edition (and 2016
Office for Registration of Medicinal Products, supplements (current)
Medical Devices and Biocidal Products 8th Edition (and 2013-
Al. Jerozolimskie 181C supplements) 2011
PL-02-222 Warsaw 7th Edition (and 2012-
Website: http://www.urpl.gov.pl (Polish, English) supplements) 2008-
Email: ewa.leciejewicz@urpl.gov.pl 6th Edition 2011
5th Edition 2006
2. Office for Registration of Medicinal Products, Medical Supplement
Devices and Biocidal Products 4th Edition 2002
Al. Jerozolimskie 181C Volume 1 1990
02-222 Warsaw, Poland Volume 2 1995
3rd Edition
3. Website: Supplement 1 1965
http://www.urpl.gov.pl (Polish, English) Supplement 2 1970
Supplement 3 1954
2nd Edition 1956
4. Yearly 1st Edition 1959
1962
1946
1817
Working document QAS/11.453/Rev.10
page 25
Portugal* Farmacopeia Secrétariat de la Pharmacopée Portugaise 9th Edition, 2008 Portuguese
Portuguesa Faculdade de Farmacia Vol. 1,Vol. 2,Vol. 3 2008
Rua Anibal Cunha Supplement 9.1 2008
Supplement 9.2 2009
P-4050 Porto Supplement 9.3 2009
Website: Supplement 9.4 2009
http://www.infarmed.pt (Portuguese, English) Supplement 9.5 2010
Email: slobo@ff.up.pt Supplement 9.6 2010
Supplement 9.7 2010
Supplement 9.8 2005
8th Edition, Vol. 1,Vol. 2 2002
7th Edition, Vol. 1,Vol. 2 1997
6th Edition 2000
Supplement
4. Once in 5 years
Ukraine* The State 1. The Ukrainian Scientific Pharmacopoeial Center for 2nd Edition (2.0) Vol. 1 2015 Ukrainian
Pharmacopoeia Quality of Medicines Vol. 2 2014
of Ukraine 33, Astronomicheskaya Str. Vol. 3 2014
(ДЕРЖАВНА Kharkov, Ukraine, 61085 Supplement 4 (1.4) 2011 Ukrainian
ФАРМАКОПЕЯ Website: http://www.sphu.org Supplement 3 (1.3) 2009 Ukrainian
УКРАЇНИ) Email: phukr@phukr.kharkov.ua Supplement 2 (1.2) 2008 Ukrainian, Russian
State Administration of Ukraine on Medicinal Products Supplement 1 (1.1) 2004 Ukrainian, Russian
Ministry of Health of Ukraine 1st Edition (1.0) 2001 Ukrainian, Russian
4. Yearly
United States The United 1. & 2. The United States Pharmacopeia USP 36, NF 31 2012 English, Spanish
of America States 12601 Twinbrook Parkway Supplement 1 2013
Pharmacopeia Rockville, MD 20852 -1790, USA Supplement 2 2013
and Website: http://www.usp.org (English, Spanish, Chinese, USP 35, NF 30 2011 English, Spanish
National Portuguese) Supplement 1 2012
Formulary Email:execsec@usp.org Supplement 2 2012
(USP-NF) USP 34, NF 29 2010
Supplement 1 2011
Supplement 2 2011
Five-year Revisions: 1942-
3. USP-NF 2000
http://www.uspnf.com/uspnf/login
_______________
Eurasia** Pharmacopoeia of the 1. Pharmacopoeial Committee of the Eurasian Economic 1st Edition 2018-2019 Ru
Eurasian Economic Union Union
Eurasian Economic Commission
Smolensky boulevard 3/5, bld 1
Moscow 119121, Russian Federation
3. Websites:
http://www.eurasiancommission.org/ru/act/texnreg/deptexreg
/LS1/Pages/pharmacopoeia.aspx; http://dosc.eaeunion.org/ru-
ru.
Participating countries in the Pharmacopoeia of the EAEU are: Armenia; Belarus; Kazakhstan; Kyrgyzstan; and the Russian Federation.
The draft Pharmacopoeia of the EAEU is preparing by the Pharmacopoeial Committee of the EAEU.
The Pharmacopoeial Committee of the EAEU consists of representatives of Armenia; Belarus; Kazakhstan; Kyrgyzstan; and the Russian Federation (8
persons per each member state of EAEU).
Working document QAS/11.453/Rev.10
page 33
European Pharmacopoeia 1. & 2. European Directorate for the Quality of 9th Edition (9.0) 2016 English, French
Medicines & HealthCare, Council of Europe 8th Edition 2014 English, French,
7 allée Kastner, CS 30026 7th Edition 2011 Spanish
F-67081 Strasbourg 6th Edition 2008
Website:http://www.edqm.eu (English, French) 5th Edition 2005
Email: caroline.letarnec@edqm.eu 4th Edition 2002
3rd Edition 1997
2nd Edition 1980
3. European Pharmacopoeia 1st Edition 1967
http://online.edqm.eu/entry.htm
37 Member States and the European Union are signatory to the Convention on the Elaboration of a European Pharmacopoeia.
European Pharmacopoeia Members:
Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary,
Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain,
Sweden, Switzerland, "the former Yugoslav Republic of Macedonia", Turkey, Ukraine, United Kingdom, and the European Union.
European Pharmacopoeia Observers:
Albania, Algeria, Argentina, Armenia, Australia, Azerbaijan, Belarus, Brazil, Canada, China, Georgia, Guinea, Israel, Kazakhstan, Republic of Korea,
Madagascar, Malaysia, Republic of Moldova, Morocco, Russian Federation, Senegal, Singapore, South Africa, Syria, Tunisia, the United States of America,
the Taiwan Food and Drug Administration (TFDA) and the World Health Organization (WHO).
Working document QAS/11.453/Rev.10
page 34
European Pharmacopoeia
Africa African Pharmacopoeia 1&2. Committee on Scientific and Technical Vol. 1 1985 English
Research, African Union (AU-STRC) Vol. 2 1986 English
26/28 NPA BUILDING
4th Floor
Marina, Lagos, Nigeria
Website: http://au-strc.org/en/excdir.asp (English)
Contact: http://au-strc.org/en/contactus.asp
African Herbal Pharmacopoeia 1&2. Association for African Medicinal Plants 1st Edition 2010 English
(AfrHP) Standards
C/O Executive Services Ltd
2nd Les Jamalacs Building,
Vieux Conseil Street
Port Louis, Mauritius
Website: http://www.aamps.org (English,
French)
Email: secretary@aamps.org
Working document QAS/11.453/Rev.10
page 35
III. INTERNATIONAL
WHO, Geneva
The International 1. WHO Expert Committee on Specifications for 5th Edition 2016 English
Pharmacopoeia Pharmaceutical Preparations
Website: 4th Edition, Vols 1, 2 2006
http://www.who.int/medicines/services/expertco 1st 2008
mmittees/pharmprep/en/index.html (English) Supplement
Emails: empinfo@who.int, qsm@who.int 2nd 2011
Supplement
2. WHO Press 3rd 2013
World Health Organization, Supplement
1211 Geneva 27, Switzerland 4th 2014
Fax: (41-22) 791 48 57 Supplement
Email: bookorders@who.int
***